The Second People's Hospital of Shenzhen

The Second People's Hospital of Shenzhen: A Global Healthcare Benchmark for Beijing-Shenzhen Integration

The Second People's Hospital of Shenzhen (Peking University Shenzhen Clinical Medical College, Shenzhen Peking University Hospital) is a directly affiliated hospital of Peking University and a national Class III Grade A comprehensive hospital. It serves as a key institution for Guangdong Province's high-level hospital development initiative and the core platform for Shenzhen's “Three Excellence Project” (distinguished physicians, hospitals, and clinics). Located in Futian District, Shenzhen—a core city within the Guangdong-Hong Kong-Macao Greater Bay Area—the hospital adjoins Lianhua Mountain Park. Spanning 59,000 square meters with a total floor area exceeding 210,000 square meters, it offers over 2,600 beds, handles more than 6.5 million outpatient and emergency visits annually, and discharges over 120,000 patients yearly. Serving as Peking University Health Science Center's “bridgehead for medical research” in Shenzhen, the hospital deeply integrates Peking University's academic heritage with Shenzhen's innovative vitality. It has evolved into a modern medical center in South China, integrating medical care, teaching, research, prevention, and health preservation.

I. Hospital Overview: Beijing-Shenzhen Synergy, Building a Medical Hub

Founded in 1999 through a collaboration between Peking University and the Shenzhen Municipal Government, the hospital commenced operations in 2001. In 2011, it became the Peking University Shenzhen Clinical Medical College, undertaking undergraduate, master's, doctoral, and standardized residency training programs. With over 4,000 staff members, including more than 700 senior-level professionals and over 280 PhDs and postdoctoral researchers, the hospital brings together top-tier experts such as members of the Chinese Academy of Engineering, Changjiang Scholars, and recipients of the National Science Fund for Distinguished Young Scholars, alongside key faculty from Peking University Health Science Center's various disciplines.

As a designated National Regional Medical Center (South China) and a National Project for Enhancing Diagnosis and Treatment Capabilities for Complex and Critical Illnesses, the hospital pursues a strategy of “strengthening specialties and optimizing comprehensive services.” It focuses on critical care, complex disease management, and cutting-edge technology development while serving as Shenzhen's emergency response hub for major public health incidents. The hospital stands as a core node in the coordinated medical development of the Guangdong-Hong Kong-Macao Greater Bay Area.

II. Technological Advantages: Beijing Research, Shenzhen Application—Leading Minimally Invasive and Precision Medicine

Leveraging the research strengths of Peking University Health Science Center, the hospital focuses on four key breakthrough areas: minimally invasive surgery, precision medicine, organ transplantation, and smart healthcare. Multiple technologies have reached nationally leading and internationally advanced levels:

• Minimally Invasive and Robotic Surgery: Among the first hospitals in South China to introduce the Da Vinci Surgical System (Xi), having performed over 4,000 robot-assisted procedures across urology (prostate cancer radical resection, partial nephrectomy), thoracic surgery (lung cancer resection), and gastrointestinal surgery (gastric/colorectal cancer resection). These techniques offer minimal trauma, rapid recovery, and nationally leading technical maturity.

• Organ Transplantation and Regenerative Medicine: The only hospital in Shenzhen authorized for liver, kidney, heart, and lung transplants, performing over 200 organ transplants annually with a one-year liver transplant survival rate exceeding 95%. Concurrently advancing frontier fields like stem cell therapy and tissue engineering, including a joint laboratory established with Peking University Stem Cell Research Center.

• Precision Medicine and Oncology: Home to Guangdong Provincial Key Laboratory of Translational Oncology and Shenzhen Key Laboratory of Precision Medicine, the hospital offers tumor gene testing (NGS), multi-omics analysis, immunotherapy (PD-1/PD-L1 inhibitors), and targeted therapies. It maintains remote consultation partnerships with MD Anderson Cancer Center and Johns Hopkins Hospital.

• Smart Hospital Development: As one of China's first Level 6 Electronic Medical Record Hospitals, it has launched AI-assisted diagnostic systems (e.g., intelligent CT analysis for pulmonary nodules, mammography screening), a 5G remote surgical guidance platform, and intelligent logistics robots (for medication delivery and specimen transport). This enables “cross-Bay Area mutual recognition” of test results and “real-time online response” for multidisciplinary consultations (MDT).

III. Leading Specialties: Strength in Specialized Care, Excellence Across Multiple Fields

The hospital's specialty development spans comprehensive coverage, with 15 disciplines designated as national/provincial key specialties, forming a structure of “peak leadership and tiered collaboration”:

• National Key Specialties: Obstetrics and Gynecology (National Clinical Key Specialty; IVF success rate exceeding 60%; South China Assisted Reproductive Technology Training Center), Urology (National Clinical Key Specialty; nationally renowned for early prostate cancer diagnosis and robotic surgery), Cardiology (Annual procedures exceeding 4,000 for coronary intervention and radiofrequency ablation of arrhythmias)

• Provincial Key Specialties: Orthopedics (spinal deformity correction and joint replacement techniques at the national forefront), Critical Care Medicine (South China ICU Quality Control Center, sepsis treatment success rate exceeding 85%), Oncology (National Cancer Center Collaborative Unit, offering precision radiotherapy and immunotherapy combinations), Radiology (3.0T MRI functional imaging, diagnostic imaging for cardiothoracic diseases).

• Specialized Departments: Ophthalmology (SMILE femtosecond laser vision correction, myopia prevention and control for children and adolescents), Dermatology and Venereology (treatment of complex skin diseases, biologic therapy for psoriasis), Rehabilitation Medicine (neurological rehabilitation, enhanced recovery after surgery), all with significant regional influence.

IV. Departments and Medical Equipment: Comprehensive Support for High-Quality Care

The hospital features a comprehensive departmental structure encompassing over 50 clinical, medical technology, and public health departments, including:

• Core Clinical Departments: Emergency Medicine, Cardiology, Urology, Obstetrics and Gynecology, Orthopedics, Oncology, Neurosurgery, Thoracic Surgery, Pediatrics, Critical Care Medicine, all recognized as flagship departments.

• Advanced Medical Technology Departments: Radiology (equipped with 3.0T MRI, 256-slice spiral CT, PET-CT), Ultrasound Medicine (ultrasound-guided interventional therapy), Pathology (fully automated diagnostic system), Laboratory Medicine (ISO 15189 certified), providing robust support for precision diagnostics.

In terms of medical equipment, the hospital is equipped with world-class devices, including:

• Da Vinci Surgical System (Xi model), CyberKnife, and TOMOLine helical tomotherapy system;

• 3.0T MRI, 256-slice ultra-high-end spiral CT, and digital subtraction angiography (DSA) system;

• Fully automated biochemical and immunological testing lines, next-generation sequencing (NGS) instruments, flow cytometers, and other precision diagnostic equipment;

• Smart ward systems (intelligent monitoring, mobile nursing terminals), AI-powered imaging diagnosis platforms, and other intelligent facilities.

V. International Patient Services: Global Standards, Comprehensive Care

As Shenzhen's flagship hospital for international outreach, we prioritize global healthcare services through a “multilingual, full-cycle, one-stop” service system:

• Multilingual Support: Translation services in 12 languages, including English, Japanese, Korean, and Arabic (on-site and remote video interpretation). Key departments (e.g., Obstetrics & Gynecology, Urology, International Medical Department) staff bilingual medical personnel.

• International Medical Fast Track: Established an “International Medical Department” (featuring VIP outpatient clinics and special-need wards) offering priority appointments, dedicated examinations, and multidisciplinary team (MDT) consultations, reducing average waiting times to under 30 minutes.

• Insurance & Payment Convenience: Direct billing agreements with over 50 global health insurers (e.g., MSH, Cigna, Aetna, BUPA) support overseas insurance settlements. Extended services include cross-border medical visa assistance, accommodation booking, and airport transfers.

• Cultural Adaptation Services: Respecting diverse patient customs, we provide religious facilities (Christian chapels, prayer rooms), customized dietary options (halal meals, vegetarian, gluten-free), and holiday observances (Chinese New Year, Christmas, etc.) for personalized care.

VI. Medical Rankings: Leading Nationally with Distinguished Specialties

• Domestic Rankings: In Fudan University's 2023 China Hospital Rankings, the hospital ranked 12th among comprehensive hospitals in South China. Its Obstetrics and Gynecology department has been among the top ten nationally for six consecutive years, while Urology ranks within the top 20 nationwide. In Guangdong Province's High-Level Hospital Development initiative, it has been rated “Excellent” for four consecutive years.

• International Rankings: While not featured prominently in global comprehensive rankings like QS or Newsweek, its specialty departments enjoy significant international recognition: - Obstetrics and Gynecology designated as an “Asia-Pacific Training Center” by the International Society for Assisted Reproductive Technology (ISART); - Urology awarded “Guideline Recommendation Unit” status by the European Association of Urology (EAU); - Oncology established research collaboration with Dana-Farber Cancer Institute, affiliated with Harvard Medical School.

VII. International Patient Feedback: “Technical Excellence, Thoughtful Care”

Patients from Europe, America, Southeast Asia, and beyond consistently report:

• “I underwent IVF at Peking University Shenzhen Hospital with a higher success rate than expected! Doctors explained each treatment step in English, and nurses translated prenatal reports, making my fertility journey abroad reassuring.” (Emily, U.S. patient)

• “My father underwent robotic prostate cancer surgery here and was mobile the day after. The surgeon followed up weekly via video call—this ‘postoperative care’ surpasses U.S. hospitals in detail.” (Mr. Lee, Singapore)

• "Emergency treatment for my acute myocardial infarction took just 25 minutes—from admission to balloon angioplasty completion. The efficiency amazed me! The International Medical Department coordinator communicated entirely in Japanese throughout, making me feel completely at ease." (Japanese patient Yuki)

VIII. Contact Information, Address, and Transportation Routes

• Headquarters (Single Campus): 1120 Lianhua Road, Futian District, Shenzhen (Near Lianhua West Metro Station)

• Contact: Main Switchboard 0755-83923333; International Medical Department 0755-83923333 ext. 8000; 24-Hour Emergency Hotline 0755-83923333 ext. 120.

Transportation Guide:

• Subway: Exit A at Lianhua West Station (Line 2), then walk approximately 300 meters.

• Bus: Take routes 14, 25, 35, 54, 65, 75, 104, 222, 316, 323, 333, 339, M221, M372, etc., to “Peking University Shenzhen Hospital Station”.

• Driving Directions: Navigate to “The Second People's Hospital of Shenzhen.” On-site underground parking is available (fee applies, limited spaces; public transportation is recommended).

Conclusion

From its founding in 1999 to becoming a benchmark for Beijing-Shenzhen medical integration today, The Second People's Hospital of Shenzhen has consistently upheld its mission of “Carrying Forward the Spirit of Peking University, Serving the People of Shenzhen.” Leveraging Peking University's academic resources and Shenzhen's innovative ecosystem, the hospital continues to scale new heights in medical technology. Moving forward, the hospital will deepen international collaborations and expand its global healthcare network to deliver superior, efficient, and compassionate medical services to patients across the Guangdong-Hong Kong-Macao Greater Bay Area and worldwide.

Document dated 2025-09-15 21:45 Modify